Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other financing activities (2024 - 2025)

Profound Medical has reported Other financing activities over the past 2 years, most recently at $1.0 million for Q3 2025.

  • Quarterly results put Other financing activities at $1.0 million for Q3 2025, down 32.73% from a year ago — trailing twelve months through Sep 2025 was $5.5 million (changed N/A YoY), and the annual figure for FY2025 was $1.0 million, down 79.24%.
  • Other financing activities for Q3 2025 was $1.0 million at Profound Medical, up from -$89000.0 in the prior quarter.
  • Over the last five years, Other financing activities for PROF hit a ceiling of $3.0 million in Q4 2024 and a floor of -$89000.0 in Q1 2025.